4-Cyclopentyl-11-methyl-5-sulfanyl-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one

Catalog No. :
ACDOCQ751
CAS No. :
757221-99-1
Molecular Formula :
C16H20N2OS2
Molecular Weight :
320.48

IUPAC Name:3-cyclopentyl-2-mercapto-7-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one

4-Cyclopentyl-11-methyl-5-sulfanyl-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$100.00Login to see priceInquiryInquiry
100mg95%$141.00Login to see priceInquiryInquiry
250mg95%$194.00Login to see priceInquiryInquiry
1g95%$479.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Cyclopentyl-11-methyl-5-sulfanyl-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one
IUPAC Name3-cyclopentyl-2-mercapto-7-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one
MDL No.MFCD06342816
Molecular FormulaC16H20N2OS2
Molecular Weight320.48
SMILESO=C1C(C2=C(CC(C)CC2)S3)=C3N=C(S)N1C4CCCC4
InChI KeyFRXFGMWTNXDVCD-UHFFFAOYSA-N
Synonym4-cyclopentyl-11-methyl-5-sulfanyl-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one;[1]Benzothieno[2,3-d]pyrimidin-4(1H)-one, 3-cyclopentyl-2,3,5,6,7,8-hexahydro-7-methyl-2-thioxo-
CAS No.757221-99-1

Synthetic Route by SureRoute

1. ACDOCQ751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDOCQ751 route product structure diagram
    ACDOCQ751757221-99-1
Inquiry

2. ACDOCQ751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDOCQ751 route product structure diagram
    ACDOCQ751757221-99-1
Inquiry

Comments (0)